v3.25.2
Basis of Presentation - Summary of Subsidiaries which are Wholly Owned and Subject to Control (Details)
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
ImmunoPrecise Antibodies (Canada) Ltd.      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Antibodies (Canada) Ltd.    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Canada    
Functional Currency Canadian dollar    
ImmunoPrecise Antibodies (USA) Ltd. ("IPA USA")      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Antibodies (USA) Ltd. ("IPA USA")    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation USA    
Functional Currency US dollar    
ImmunoPrecise Antibodies (N.D.) Ltd.      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Antibodies (N.D.) Ltd.    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation USA    
Functional Currency US dollar    
ImmunoPrecise Antibodies (MA) LLC      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Antibodies (MA) LLC    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation USA    
Functional Currency US dollar    
Talem Therapeutics LLC ("Talem")      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary Talem Therapeutics LLC ("Talem")    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation USA    
Functional Currency US dollar    
ImmunoPrecise Netherlands B.V.      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Netherlands B.V.    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Netherlands    
Functional Currency Euro    
ImmunoPrecise Antibodies (Europe) B.V. ("IPA Europe")      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Antibodies (Europe) B.V. ("IPA Europe")    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Netherlands    
Functional Currency Euro    
BioStrand B.V.      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary BioStrand B.V.    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Belgium    
Functional Currency Euro    
Idea Family B.V.      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary Idea Family B.V.    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Belgium    
Functional Currency Euro    
BioKey B.V.      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary BioKey B.V.    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Belgium    
Functional Currency Euro    
BioClue B.V.      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary BioClue B.V.    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Belgium    
Functional Currency Euro